Navigation Links
CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Date:8/22/2007

PALO ALTO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that eight abstracts, including a clinical trial update session on anti-arrhythmia data from the MERLIN TIMI-36 study, have been accepted for presentation at the European Society of Cardiology (ESC) Congress 2007 taking place in Vienna, Austria from September 1-5, 2007.

A clinical trial update session entitled, The Effect of Ranolazine, a Novel Anti-anginal Agent with Electrophysiologic Properties, on the Incidence of Tachyarrhythmias: Results from the MERLIN-TIMI 36 Randomized Controlled Trial, is scheduled for presentation Wednesday, September 5 at 9:45 a.m. Central European Summer Time (CEST).

Other accepted abstracts include:

Ranexa(R) (ranolazine extended-release tablets):

Clinical Outcomes in Patients with Diabetes or the Metabolic Syndrome Presenting with Non- ST-elevation Acute Coronary Syndrome in the MERLIN- TIMI 36 Trial; Poster, Sunday, September 2, 8:30 a.m.-12:30 p.m. CEST

Cost of Angina:

Recurrent Angina Following Revascularization - Frequency, Patient Characteristics and Costs; Poster, Wednesday, September 5, 8:30 a.m. - 12:30 p.m. CEST

Late Sodium Current:

Reduction of Repolarization Reserve Unmasks the Role of Late Sodium Current in Rabbit Isolated Hearts; Poster, Sunday, September 2, 8:30 a.m. - 12:30 p.m. CEST

Mechanism of Ranolazine Block of Cardiac Na Channels; Poster, Monday, September 3, 2:00 - 6:00 p.m. CEST

Regadenoson

Results from Two Randomized, Double-blind, Placebo-controlled Trials Evaluating the Safety of Regadenoson in Patients with Reactive Airways Disease; Poster, Tuesday, September 4, 2:00 - 6:00 p.m. CEST


'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014  Millions of people suffer from neck ... Recently the FDA approved the launch of ... innovative implant device developed by Spinal Kinetics, which may offer ... and or arm pain. Hospital for Special Surgery (HSS), the ... hospital in New York City and ...
(Date:9/17/2014)... According to a new market research report ... Display, & Microprocessor/MCU), by Application (Imaging, Medical Therapeutics, Diagnosis, ... Global Forecast to 2020", published by MarketsandMarkets, the total ... $56.50 Billion by 2020, growing at a CAGR of ... market data Tables and 71 Figures spread through 312 ...
(Date:9/17/2014)... N.J. , Sept. 17, 2014  The ... (MDM&C), today announced that it will serve as ... Benefits and Avoiding the Risks of Healthcare Reform," ... that will examine delivery systems, reimbursement, compliance and ... Care Act. Logo -  http://photos.prnewswire.com/prnh/20140916/146606 ...
Breaking Medicine Technology:Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2
... Pa., Jan. 12, 2011 ECRI Institute® ( ... the best approaches to improving patient care, is ... Health Devices Achievement Award program. The award ... technology management. (Logo: http://photos.prnewswire.com/prnh/20110112/DC29081LOGO ...
... 2011, what will be the major trends in the ... regulations affect what,s next and what,s new?  What will ... competitive corporate landscape?  When it comes to market research, ... the job done right? The answers to these questions ...
Cached Medicine Technology:ECRI Institute's 2011 Health Devices Achievement Award - Call for Entries 2ECRI Institute's 2011 Health Devices Achievement Award - Call for Entries 3Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event 2
(Date:9/17/2014)... -- Present-day Europeans are the descendants of at ... a new study. Previous research suggested ... European farmers. But, a new genetic analysis involving ... descendants of Ancient North Eurasians. Nearly all present-day ... group, researchers from Harvard Medical School said. , ...
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- Managing diabetes, ... a healthy weight can reduce the risk for dementia ... The World Alzheimer Report 2014, commissioned by ... risk of dementia by 50 percent. The study noted ... factors for diabetes as well as high blood pressure. ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, ... to artificial sweeteners to soothe their sweet tooth may ... study suggests. Artificial sweeteners can potentially make blood ... in human and mouse studies. That,s because saccharine ... in the intestines in ways that can impair some ...
(Date:9/17/2014)... COLUMBUS, Ohio Mathematics might be able to reduce ... damage related to the autoimmune disease lupus. , In ... can predict the progression from nephritis kidney inflammation ... current treatments cannot reverse. A kidney biopsy is the ... the damage and its extent. , The model could ...
(Date:9/17/2014)... Research has shown that most 18-month-olds learn an average ... little is known about how children process information to ... years. In a new study, a University of Missouri ... they age, and a limit exists as to how ... could help parents enhance their children,s vocabularies and assist ...
Breaking Medicine News(10 mins):Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 3Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Math model designed to replace invasive kidney biopsy for lupus patients 2Health News:Babies learn words differently as they age, researcher finds 2
... Blacksburg, Va. -- A new yew species that grows in ... Kingston, University Distinguished Professor of Chemistry in Virginia Tech,s College ... was described by Richard Spjut in a major review of ... Institute of Texas. , The author says, Taxus kingstonii ...
... small businesses and ... individuals, ... Milwaukee, WI-based national provider of,individual medical, small group and specialty health ... announced today the formation of a new health care network., ...
... CHICAGO, Nov. 27 The past decade has seen ... pregnant women,according to a study presented today at the ... "Through medical imaging examinations, we are exposing pregnant ... 10 years ago," said Elizabeth,Lazarus, M.D., assistant professor of ...
... Vision Reach to be deployed at 92 outpatient imaging ... centers ... AMCS ),a leader in radiology and medical image and information ... diagnostic imaging services, has chosen AMICAS Vision,Series(TM) PACS as the platform ...
... drug recall notice -- creating a,new paradigm for the ... safety,experts, including representatives from the Center for Medicine in ... will gather,at the National Press Club and call for ... individualized information about the risks and,benefits of drugs on ...
... the American Lung Association,s Faces of Influenza Program to ... Urge Immunization throughout the Season, ... up 20% of the population, or 757,000 people, are estimated ... Americans are,recommended for annual vaccination, immunization rates fall short every,year, ...
Cached Medicine News:Health News:Tree named in honor of Virginia Tech chemist David G.I. Kingston 2Health News:Low-Cost Health Care Network Launches in Lubbock 2Health News:Low-Cost Health Care Network Launches in Lubbock 3Health News:Radiation Exposure of Pregnant Women More than Doubles in 10 Years 2Health News:Radiation Exposure of Pregnant Women More than Doubles in 10 Years 3Health News:MedQuest Standardizes on AMICAS Vision Series PACS 2Health News:MedQuest Standardizes on AMICAS Vision Series PACS 3Health News:Drug Safety Experts Call for Increased Patient Involvement 2Health News:Drug Safety Experts Call for Increased Patient Involvement 3Health News:Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 2Health News:Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 3Health News:Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: